How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies

Reagan Patrick M.; Neelapu Sattva S.

首页> 外文期刊>Journal of Clinical Oncology >How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies

【24h】

How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies

机译：我如何管理：嵌合抗原受体T细胞疗法的病理生理学和毒性管理

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2021年第5期|共12页
作者
Reagan Patrick M.; Neelapu Sattva S.;
展开▼
作者单位

Univ Rochester Med Ctr Wilmot Canc Inst 601 Elmwood Ave Box 704 Rochester NY 14642 USA;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Chimeric antigen receptor-engineered T-cell therapy for liver cancer [J] . Yang Chen, Chang-Yong E, Zhi-Wen Gong, 国际肝胆胰疾病杂志（英文版） . 2018,第004期
2. The human application of gene therapy to re-program T-cell specificity using chimeric antigen receptors [J] . Alan DGuerrero, Judy SMoyes, Laurence JN Cooper 癌症（英文版） . 2014,第009期
3. Tumor Antigen Specific Activation of Primary Human T-Cells Expressing a Virally Encoded Chimeric T-Cell Receptor Specific for p185HER2 [J] . 杨建民, MichaelSFRIEDMAN, ChristopherMREYNOLDS, 中华微生物学和免疫学：英文版 . 2004,第004期
4. Chimeric antigen receptor T-cell therapy for the treatment of aggressive B-cell non-Hodgkin lymphomas: efficacy, toxicity, and comparative chimeric antigen receptor products [J] . Bradley D. Hunter, Michael Rogalski Caron A. Jacobson Expert opinion on biological therapy . 2019,第7a12期

机译：嵌合抗原受体T细胞疗法治疗侵袭性B细胞非霍奇金淋巴瘤：疗效，毒性和比较嵌合抗原受体产物
5. Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy-Related Toxicities [J] . Dholaria Bhagirathbhai R., Bachmeier Christina A., Locke Frederick BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy . 2019,第1期

机译：嵌合抗原受体T细胞治疗相关毒性的机制和管理
6. Chimeric antigen receptor T-cell therapy - assessment and management of toxicities [J] . Neelapu Sattva S., Tummala Sudhakar, Kebriaei Partow, Nature reviews. Clinical oncology . 2018,第1期

机译：嵌合抗原受体T细胞治疗 - 评估和管理毒性
7. Main Issues and Current Strategies in Enhancing the Efficacy of Chimeric Antigen Receptor T-Cell Therapy among Tumor Treatments [C] . Zhengting He International Conference on Frontiers of Biological Sciences and Engineering . 2020

机译：提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
8. The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies. [D] . Koduri, Megha Pallavi. 2017

机译：嵌合抗原受体T细胞疗法对B细胞恶性肿瘤的治疗潜力。
9. Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials Pathophysiology and Management Strategies [O] . Xiang Zhou, Leo Rasche, K. Martin Kortüm, 2020

机译：多发性骨髓瘤中嵌合抗原受体T细胞疗法的毒性：临床试验病理生理学和管理策略的经验概述
10. Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management Strategies [O] . Xiang Zhou, Leo Rasche, K. Martin Kortüm, 2020

机译：多发性骨髓瘤中嵌合抗原受体T细胞疗法的毒性：临床试验，病理生理学和管理策略的经验概述
11. Chimeric Enzyme/Prodrug Therapy as Novel Gene Therapy for Breast Cancer [R] . Cooper, D. L. 1997

机译：嵌合酶/前药治疗作为乳腺癌的新型基因治疗

How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies

著录项

引文网络

相似文献

相关主题

期刊订阅